APA (7th ed.) Citation

Tian C, Yang Y, Li B, Liu M, He X, Zhao L, . . . Chu XM. (2022). Doxorubicin-Induced Cardiotoxicity May Be Alleviated by Bone Marrow Mesenchymal Stem Cell-Derived Exosomal lncRNA via Inhibiting Inflammation. Dove Medical Press.

Chicago Style (17th ed.) Citation

Tian C, Yang Y, Li B, Liu M, He X, Zhao L, Song X, Yu T, and Chu XM. Doxorubicin-Induced Cardiotoxicity May Be Alleviated by Bone Marrow Mesenchymal Stem Cell-Derived Exosomal LncRNA via Inhibiting Inflammation. Dove Medical Press, 2022.

MLA (9th ed.) Citation

Tian C, et al. Doxorubicin-Induced Cardiotoxicity May Be Alleviated by Bone Marrow Mesenchymal Stem Cell-Derived Exosomal LncRNA via Inhibiting Inflammation. Dove Medical Press, 2022.